Abstract
Purpose
Oxaliplatin (OX) and 5-fluorouracil (5-FU) are the most widely used chemotherapeutic agents in the adjuvant treatment of colon cancer. Although the early initiation of adjuvant chemotherapy can improve the outcome of surgery, it carries potentially fatal risks. This experimental study investigates the effects of 5-FU and OX on colon anastomoses.
Methods
We used 60 rats, divided into six groups. After being subjected to bowel resection and anastomosis, the rats were given 5-FU on days 1–3, or OX 130 mg/m2 on days 1 or 5, or 5% dextrose as a control. The bursting pressures and hydroxyproline content of the anastomoses were measured, and complications and adhesions were recorded.
Results
There were no major complications in the treatment groups. The bursting pressures of the 5-FU group were significantly lower than those of the control and OX groups. The bursting pressures of the OX groups were not significantly different from those of the control groups. The hydroxyproline levels of the rats treated with OX on day 1 were significantly lower than those of the rats treated with OX on day 5 and the 5-FU groups.
Conclusion
Oxaliplatin and 5-FU did not compromise wound healing of the colon significantly. Our results indicate that OX is less detrimental to the healing of colonic anastomoses, when administered on days 1 and 5 after resection, than 5-FU.
Similar content being viewed by others
References
MacDonald JS, Astrow AB. Adjuvant therapy in colon cancer. Semin Oncol 2001;28:30–40.
Sobrero A, Kerr D, Glimeliue E, Van Cutsem E, Milano G, Pritchard DM, et al. New directions in the treatment of colorectal cancer: a look to the future. Eur J Cancer 2000;36:559–566.
Van der Kolk BM, De Mann BM, Wobbes T, Hendriks T. Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine. Br J Cancer 1999;79:545–550.
Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989;76:1082–1090.
Fischer B, Gündüz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488–1492.
Herrmann JB, Woodward SC, Pulaski EJ. Healing of colonic anastomoses in the rat. Surg Gynecol Obstet 1964;26:269–275.
Jiborn H, Ahonen J, Zederfeldt B. Healing of experimental colonic anastomoses. Am J Surg 1978;136:595–599.
Graf W, Weiber S, Jiborn H, Pahlman L, Glimelius B, Zederfelt B. The roles of nutritional depletion and drug concentration in 5-fluorouracil induced inhibition of colonic healing. J Surg Res 1994;56:452–456.
Barbul A. Wound healing. In: Brunicardi FC, editor. Schwartz principles of surgery. 8th ed. New York: McGraw-Hill; 2005. p. 228–230.
Koçak İ., Ünlü C, Akçan Y, Yakın K. Reduction of adhesion formation with cross-linked hyaluronic acid after peritoneal surgery in rats. Fertil Steril 1999;72:873–878.
Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1963;35:1961–1965.
Switzer BR, Summer GK. Improved methods for analysis in tissue hydrolyzates. Anal Biochem 1971;39:487–491.
Kuzu MA, Köksoy C, Kale T, Demirpençe E, Renda N. Experimental study of preoperative 5-fluorouracil on the integrity of colonic anastomoses. Br J Surg 1998;85:236–239.
Raymond E, Fahro B, Chaney S. Cellular and molecular pharmacology of oxaliplatin, Review. Mol Cancer Ther 2002;1:227–235.
Saris CP, Van de Vaart PJ, Rietbroek RC, Blommaert FA. In vitro formation of DNA adducts by cisplatin lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis 1996;17:2763–2769.
Stoop MJ, Dirksen R, Hendriks T. Advanced age alone does not suppress anastomotic healing in the intestine. Surgery 1996;119:15–19.
Wise L, Mc Alister W, Stein T, Schuck P. Studies on the healing of anastomoses of small and large intestines. Surg Gynecol Obstet 1975;141:190–194.
Zuidewijn R, Hendriks T, Wobbes T, de Boer HM. Intraperitoneal cytostatics impair healing of experimental intestinal anastomoses. Br J Cancer 1991;63:937–941.
Graf W, Staffan W, Jiborn H, Pahlman L, Glimelius B, Zederfelt B. The roles of nutritional depletion and drug concentration in 5-fluorouracil induced inhibition of colonic healing. J Surg Res 2000;56:452–456.
Weiber S, Graf W, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Experimental colonic healing in relation to timing of 5-fluorouracil therapy. Br J Surg 1994;81:1677–1680.
Stoop MJ, Dirksen R, Wobbes T, Hendriks T. Effects of early postoperative 5-fluorouracil and ageing on the healing capacity of experimental intestinal anastomoses. Br J Surg 1998;85:1535–1538.
Nayci A, Çakmak M, Renda N, Aksoyek S, Yücesan S. Effect of electromagnetic fields and early postoperative 5-fluorouracil on the healing of colonic anastomoses. Int J Colorectal Dis 2003;18:136–141.
Kanellos I, Odisseos C, Kazantzidou D, Galovatsea K, Dadoukis I. Effect of early versus delayed postoperative injection of 5-fluorouracil plus interferon alpha on colonic healing. Eur Surg Res 1998;30:414–418.
Armand JP, Boige V, Raymond E, Fiazzi K, Faivre S, Ducreux M. Oxaliplatin in colorectal cancer: an overview. Semin Oncol 2000;27:96–104.
Becouarn Y, Rougier P. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer. Semin Oncol 1998;25:23–31.
Misset JL, Bleiberg H, Sutherland W, Bekradda M, Cvitkovic E. Oxaliplatin clinical activity: a review. Crit Rev Oncol Hematol 2000;35:75–93.
De Gramont A, Banzi M, Navarro M. Oxaliplatin/5-FU/LV in adjuvant colon cancer: results of the international randomized MOSAIC trial. Proc Annu Meet Am Assoc Cancer Res 2003;22:1015–1023.
Kanellos I, Odisseos C, Kazantzidou D, Galovatsea K, Dadoukis I. Colonic healing after early intraperitoneal administration of 5-fluorouracil and interferon in rats. Int J Colorectal Dis 1997;12:45–48.
Kanellos I, Kavouni A, Zaraboukas T, Odisseos C, Dadoukis I. Influence of intraperitoneal 5-fluorouracil plus folinic acid on the healing of colonic anastomoses in rats. Eur Surg Res 1996;28:374–379.
Jonsson K, Jiborn H, Zederfeldt B. Mechanical and biochemical alterations in the intestinal wall adjacent to an anastomosis. Am J Surg 1986;151;387–390.
Van der Kolk BM, de Man BM, Wobbes T, Hendriks T. Is early postoperative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine. Br J Cancer 1999;79:545–550.
Arikan Y, Senel F, Akman Y, Can C. Comparison of the effects of various anticancer agents on intestinal anastomosis after intraperitoneal administration. Surg Today 1999;29:741–746.
Shirafuji T, Oka T, Sawada T, Tamura K, Kishimoto K, Yamamoto S, et al. The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents. Surg Today 2001;31:308–316.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ersoy, E., Akbulut, H. & Moray, G. Effects of oxaliplatin and 5-fluorouracil on the healing of colon anastomoses. Surg Today 39, 38–43 (2009). https://doi.org/10.1007/s00595-008-3795-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-008-3795-6